SHL Telemedicine Ltd American Depositary Shares (SHLT) - Total Liabilities
Based on the latest financial reports, SHL Telemedicine Ltd American Depositary Shares (SHLT) has total liabilities worth $41.51 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SHLT cash flow metrics to assess how effectively this company generates cash.
SHL Telemedicine Ltd American Depositary Shares - Total Liabilities Trend (2002–2024)
This chart illustrates how SHL Telemedicine Ltd American Depositary Shares's total liabilities have evolved over time, based on quarterly financial data. Check SHL Telemedicine Ltd American Depositary liquidity resilience to evaluate the company's liquid asset resilience ratio.
SHL Telemedicine Ltd American Depositary Shares Competitors by Total Liabilities
The table below lists competitors of SHL Telemedicine Ltd American Depositary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dierig Holding AG
XETRA:DIE
|
Germany | €76.08 Million |
|
Naos Small Cap Opportunities Company Ltd
AU:NSC
|
Australia | AU$13.28 Million |
|
Mohenz.Co.Ltd
KQ:006920
|
Korea | ₩19.16 Billion |
|
Jentayu Sustainables Bhd
KLSE:5673
|
Malaysia | RM63.70 Million |
|
Bio-Works Technologies AB
ST:BIOWKS
|
Sweden | Skr22.52 Million |
|
Wellbiotec Co. Ltd.
KO:010600
|
Korea | ₩11.76 Billion |
|
Camino Minerals Corporation
V:COR
|
Canada | CA$4.13 Million |
|
TransAct Technologies Incorporated
NASDAQ:TACT
|
USA | $13.21 Million |
Liability Composition Analysis (2002–2024)
This chart breaks down SHL Telemedicine Ltd American Depositary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SHL Telemedicine Ltd American Depositary market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SHL Telemedicine Ltd American Depositary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SHL Telemedicine Ltd American Depositary Shares (2002–2024)
The table below shows the annual total liabilities of SHL Telemedicine Ltd American Depositary Shares from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $41.51 Million | +13.46% |
| 2023-12-31 | $36.59 Million | -28.95% |
| 2022-12-31 | $51.49 Million | -25.19% |
| 2021-12-31 | $68.83 Million | +155.53% |
| 2020-12-31 | $26.94 Million | +7.50% |
| 2019-12-31 | $25.06 Million | +40.43% |
| 2018-12-31 | $17.84 Million | -50.84% |
| 2017-12-31 | $36.29 Million | -6.49% |
| 2016-12-31 | $38.81 Million | +21.84% |
| 2015-12-31 | $31.86 Million | +3.66% |
| 2014-12-31 | $30.73 Million | -22.41% |
| 2013-12-31 | $39.60 Million | +2.21% |
| 2012-12-31 | $38.75 Million | -6.93% |
| 2011-12-31 | $41.63 Million | +104.40% |
| 2010-12-31 | $20.37 Million | -4.25% |
| 2009-12-31 | $21.27 Million | -6.50% |
| 2008-12-31 | $22.75 Million | -72.81% |
| 2007-12-31 | $83.67 Million | -15.07% |
| 2006-12-31 | $98.51 Million | +1.99% |
| 2005-12-31 | $96.59 Million | -15.44% |
| 2004-12-31 | $114.23 Million | +4.92% |
| 2003-12-31 | $108.87 Million | -6.01% |
| 2002-12-31 | $115.83 Million | -- |
About SHL Telemedicine Ltd American Depositary Shares
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company als… Read more